RNAi and CRISPR screening products and services. Characterize therapeutic targets/drugs, and identify mechanism of action. Discover novel biomarkers.
http://www.cellecta.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
3.7 seconds
16x16
32x32
64x64
Cellecta, Inc.
Karim Hyder
320 ●●●● Ave
Moun●●●●View , CA, 94043
US
View this contact
Cellecta, Inc.
Karim Hyder
320 ●●●● Ave
Moun●●●●View , CA, 94043
US
View this contact
Cellecta, Inc.
Karim Hyder
320 ●●●● Ave
Moun●●●●View , CA, 94043
US
View this contact
BUY YOUR DOMAIN
18
YEARS
1
MONTHS
3
DAYS
HOSTOPIA.COM INC. D/B/A APLUS.NET
WHOIS : whois.names4ever.com
REFERRED : http://www.aplus.net
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
55
SITE IP
64.111.113.60
LOAD TIME
3.679 sec
SCORE
6.2
RNAi and CRISPR Screening, Drug Target and Biomarker Discovery | cellecta.com Reviews
https://cellecta.com
RNAi and CRISPR screening products and services. Characterize therapeutic targets/drugs, and identify mechanism of action. Discover novel biomarkers.
IIS7
cellecta.com
HT Genetic Screening Products and Services - Cellecta, Inc
https://www.cellecta.com/products-services/cell-line-engineering/custom-reporter-cells
KO / KD Validation. Expression & Reporter. RNAi and shRNA Design. ShRNA and CRISPR Libraries. Webinar: RNAi & CRISPR Screens. User Manuals / PACs. HT Genetic Screening Products and Services. To discuss. Much of our technology development begins as collaborations to solve practical research challenges. CRISPR Products and Services. ShRNA Products and Services. HT Genetic Screening Services. Pooled Lentiviral CRISPR, shRNA, and Barcode Libraries. Isogenic Cell Line Engineering. Product & Services.
Gene Knockdown or Knockout Validation - Cellecta, Inc
https://www.cellecta.com/products-services/cellectas-complete-loss-of-function-screening-services/gene-knockdown-or-knockout-validation
KO / KD Validation. Expression & Reporter. RNAi and shRNA Design. ShRNA and CRISPR Libraries. Webinar: RNAi & CRISPR Screens. User Manuals / PACs. KO / KD Validation. Gene Knockdown or Knockout Validation. Cellecta can help validate target genes by knocking down expression in your cells of interest. Cellecta provides complete services for validation of target genes including qRT-PCR, proliferation assays, reporter assays, and custom stable knockdown or knockout cell line creation. 10 week turnaround time.
Human Genome-Wide shRNA Library - Cellecta, Inc
https://www.cellecta.com/products-services/cellecta-pooled-lentiviral-shrna-and-sgrna-libraries/human-genome-wide-shrna-library-2
KO / KD Validation. Expression & Reporter. RNAi and shRNA Design. ShRNA and CRISPR Libraries. Webinar: RNAi & CRISPR Screens. User Manuals / PACs. Human Genome-Wide shRNA Library. For Genome-Wide Coverage in Human. 3 Modules, each covering approximately 6,500 genes. Each gene is targeted by 8 hairpins for a total of approximately 55,000 hairpins per module. Modules are made with non-overlapping barcodes so that they can be combined to form a complete genome-wide shRNA library. Top-ranking genes from the ...
Custom shRNA and CRISPR Libraries - Cellecta, Inc
https://www.cellecta.com/products-services/cellecta-pooled-lentiviral-shrna-and-sgrna-libraries/custom-shrna-and-sgrna-libraries
KO / KD Validation. Expression & Reporter. RNAi and shRNA Design. ShRNA and CRISPR Libraries. Webinar: RNAi & CRISPR Screens. User Manuals / PACs. Custom Pooled shRNA and CRISPR Libraries. Construction of shRNA and CRISPR Libraries. A higher percentage of functional shRNAs, designed using validated shRNA sequences and optimized shRNA structures. Flexible array-based oligonucleotide synthesis enables rapid creation of complex libraries expressing any set of shRNAs and sgRNAs to any targets. For broad cove...
Human Genome-Wide CRISPR sgRNA Library - Cellecta, Inc
https://www.cellecta.com/products-services/cellecta-pooled-lentiviral-shrna-and-sgrna-libraries/human-crispr-genome-wide-sgrna-library
KO / KD Validation. Expression & Reporter. RNAi and shRNA Design. ShRNA and CRISPR Libraries. Webinar: RNAi & CRISPR Screens. User Manuals / PACs. Human Genome-Wide CRISPR sgRNA Library. For Genome-Wide Coverage in Human. 3 Modules, each covering approximately 6,500 genes. Each gene is targeted by up to 8 sgRNA for a total of up to 55,000 sgRNA per module. Targeting a total of over 19,000 protein encoding genes. Compatible with Illumina HiSeq, GAIIx, and NextSeq NGS systems. Download the SnapGene Viewer.
TOTAL PAGES IN THIS WEBSITE
20
Sponsors
http://www.worldpreclinicalcongress.com/Current-Sponsors
Event Features and Attendee Demographics. Exhibitor Kit / Schedule. 160; Lead Generation. 160; . 160; . 160; . For more information regarding exhibit and sponsorship, please contact:. Sr Business Development Manager. 160; iquigley@healthtech.com. Joseph Vacca, M.S. Director, Business Development. Quick Links . Event Features and Attendee Demographics. Exhibitor Kit / Schedule. 160; Media Partners. 250 First Avenue, Suite 300. Needham, MA 02494. P: 781.972.5400. F: 781.972.5425. Drug and Device Safety.
GPCR-Based Drug Discovery - Part 1
http://www.discoveryontarget.com/GPCR-drug-discovery
Conference At A Glance. G protein-coupled receptors (GPCRs) have steadily remained an important target class for drug discovery because of the myriad of biological processes they initiate as transducers of extracellular signals to inside the cell. The first meeting in our two-part set of conferences, Part 1: Screening and Structure-based Approaches. RECOMMENDED ALL ACCESS PACKAGE:. September 19 Short Course: GPCR Structure-Based Drug Discovery. Day 1 Day 2. Tuesday, September 20. Gebhard F.X. Sch...By co...
Symposium: Understanding CRISPR: Mechanisms and Applications
http://www.discoveryontarget.com/crispr-therapies
Conference At A Glance. What do we now know about the biology of CRISPR and what lessons have we learnt from working with RNA interference (RNAi)? Scientists will discuss new findings in CRISPR mechanisms and share their experiences leveraging the utility of CRISPR-based gene editing. RECOMMENDED ALL ACCESS PACKAGE:. September 19 Symposium: Understanding CRISPR: Mechanisms and Applications. September 19 Short Course: Introduction to Gene Editing. Monday, September 19. 9 FOR FUNCTIONAL SCREENING. RNAi has...
Kinase Inhibitor Discovery Conference
http://www.discoveryontarget.com/kinase-inhibitor-discovery
Conference At A Glance. Cambridge Healthtech Institute's ninth annual Kinase Inhibitor Discovery. Meeting will once again unite leading kinase inhibitor discovery and development scientists to discuss emerging targets, tools, and development strategies. September 19 Short Course: RNA as a Small Molecule Drug Target. September 20-21 Conference: Targeting Histone Methyltransferases and Demethylases. September 21-22 Conference: Kinase Inhibitor Discovery. Day 1 Day 2. Wednesday, September 21. 4:05 Design an...
Discovery On Target 2016
http://www.discoveryontarget.com/discoveryontarget_homepage.aspx
Conference At A Glance. 160; and Demethylases. Targeting the Ubiquitin Proteasome System. Targeting the Microbiome Part 1. GPCR-Based Drug Discovery - Part 1. Advances in Gene Editing. 160; and Gene Silencing Part 1. Antibodies Against Membrane Protein Targets. 160; Part 1. 160; and Chromatin Remodelers. Targeting the Microbiome Part 2. GPCR-Based Drug Discovery - Part 2. Advances in Gene Editing and. 160; Gene Silencing Part 2. Antibodies Against Membrane Protein Targets. 160; Part 2. Boston, MA 02210.
Symposium: Strategies for Tackling Rare Genetic Diseases
http://www.discoveryontarget.com/rare-diseases
Conference At A Glance. RECOMMENDED ALL ACCESS PACKAGE:. September 19 Symposium: Strategies for Tackling Rare Genetic Diseases. September 20-21 Conference: Gene Therapy Breakthroughs. September 21-22 Conference: Translating Cancer Genomics. Monday, September 19. 7:00 am Registration Open and Morning Coffee. EXPLORING NEW THERAPIES FOR TREATING RARE DISEASES. 8:30 Chairperson’s Opening Remarks. 8:40 Gene Therapy for Lysosomal Storage Diseases. Ron Lahav, Ph.D., CEO, ART Bioscience Ltd. The supplementation...
Symposium: Next-Generation Histone Deacetylase Inhibitors
http://www.discoveryontarget.com/HDAC-inhibitors
Conference At A Glance. RECOMMENDED ALL ACCESS PACKAGE:. September 19 Symposium: Next-Generation Histone Deacetylase Inhibitors. September 19 Short Course: Convergence of Immunotherapy and Epigenetics for Cancer Treatment. September 20-21 Conference: Targeting Histone Methyltransferases and Demethylases. September 21-22 Conference: Targeting Epigenetic Readers and Chromatin Remodelers. September 21 Short Course: DNA Methyl Transferase (DNMT) Inhibitors as Therapeutics. Monday, September 19. Histone deace...
Gene Therapy Breakthroughs
http://www.discoveryontarget.com/gene-therapy
Conference At A Glance. RECOMMENDED ALL ACCESS PACKAGE:. September 19 Symposium: Strategies for Tackling Rare Genetic Diseases. September 20-21 Conference: Gene Therapy Breakthroughs. September 21-22 Conference: Advances in Gene Editing and Gene Silencing - Part 2. Day 1 Day 2. Tuesday, September 20. 7:00 am Registration Open and Morning Coffee. KEYNOTE SESSION: GENOME EDITING FOR IN VIVO. 8:05 Chairperson’s Opening Remarks. 8:20 AAV for Gene Therapy and Genome Editing. Genome editing offers the prospect...
Symposia - Discovery On Target
http://www.discoveryontarget.com/dot-symposia
Conference At A Glance. Next-Generation Histone Deacetylase Inhibitors. Strategies for Tackling Rare Genetic Diseases. Understanding CRISPR: Mechanisms and Applications. Autoimmunity Small Molecule Approaches. NK Cell-Based Cancer Immunotherapy. Medical Dermatology Therapeutic R&D and Technical Innovation. 160; PREMIER SPONSOR. The exhibit hall was sold out in 2015, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2016, contact:. Monday, September 19.
Advances in Gene Editing and Gene Silencing – Part 1
http://www.discoveryontarget.com/RNAi-screens-functional-genomics
Conference At A Glance. Cambridge Healthtech Institute’s 13th annual two-part conference on Advances in Gene Editing and Gene Silencing. Will cover the latest in the use of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9-based gene editing and RNA interference (RNAi) for use in drug discovery and for developing novel drug therapies. Part 1 will cover the use of CRISPR/Cas9 and RNAi for identifying new drug targets and therapies. RECOMMENDED ALL ACCESS PACKAGE:. September 21-22 Con...
TOTAL LINKS TO THIS WEBSITE
55
Cellavista, the excellent cell imaging system by SynenTec Bio Services
ESACT UK 24th Annual Meeting. January 8-9th, 2014 Nottingham. December 2 - 4th 2013, Munich. SynenTec Bio Services is your sales and service partner for the Cellavista product range in Europe. The Cellavista is a cell imaging system and a dependable, fast and fully automized solution for tedious routine work in cell biology, cell line development and biopharmaceutical production processes. A little bit of history.
Domain ist reserviert
CELLECT
Serving Information and Ingredients. Virginia Academy of Science. Please know that CELLECT™. Or any person relative to this product do not make any implications, promises, nor guarantees that CELLECT™. Will reverse any disease. The information herein is determined informational and observational. Although the observations and documentations show positive results, it is the reader’s obligation to discuss with their medical professional, and make their own decisions. Please know that CELLECT™.
Commercial & Industrial Construction
Commercial and Industrial Construction. All Basics You Need to Know About Ready Mix Screed. What is Attic Screed? In the accent of a accurate specialist, a attic assize is a actual fabricated out of adhesive and aciculate beach in a 1:3 or 1:4.5 ratio. It is laid assimilate either a caked accurate attic assemblage or assimilate a solid in-situ accurate attic slab. Concrete Vs Assize – Is it One and Same? Both attic assize and accessible alloyed accurate are fabricated out of aforementioned capacity inclu...
Cellecta
01634 296677 or 441634 296677. Modified Beam and Block. Light Masonry Walls Timber Floors. Ultralay 3 & 5. Batten 45 & 70. 17T, 26T & 30T. 37T & Quattro. ES & FS Flanking Strips. 12c, 21c & 28c. Brochures & Samples. Insulation Project Year Book. Code for sustainable homes. Acoustic and Thermal Insulation Manufacturers. Acoustic and Thermal Insulation Manufacturers. Acoustic and Thermal Insulation Specialists. Call Now – Acoustic and thermal insulation. 8211; 01634 296 677 – Contact Form. And acoustic res...
RNAi and CRISPR Screening, Drug Target and Biomarker Discovery
CellTracker 50M Lentiviral Barcode Library. CellTracker Barcode Cell Labeling Kits. CRISPR Human Genome-Wide Knockout Libraries. Single-Module Human Genome-Wide CRISPR Library (80K). Three-Module Human Genome-Wide CRISPR Library (150K). CRISPRa CRISPRi Human Genome-Wide Libraries. CRISPR Mouse Genome-Wide Knockout Library. CRISPRa CRISPRi Mouse Genome-Wide Libraries. CRISPRtest Functional Cas9 Activity Kits (Mammalian). CRISPR Knockout Control Constructs. Human Genome-Wide shRNA Library. Genetic Screenin...
Cellectar Biosciences | Phospholipid Drug Conjugates (PDCs) for Targeted Delivery of Oncologic Payloads
How to Contact Us. News & Investors. How to Contact Us. News & Investors. Create is a multi-purpose WordPress theme that gives you the power to create many different styles of websites. How to Contact Us. News & Investors. Better Therapy Through Targeted Delivery. Scroll Down For More Information). Phospholipid Drug Conjugates (PDCs). For Targeted Delivery of Oncologic Payloads. Cellectar Biosciences is developing phospholipid drug conjugates (PDCs) designed to provide cancer targeted delivery of diverse...
Cellectar Biosciences | Novel Agents for the Treatment and Diagnosis of Cancer
Posters & Publications. I-124-CLR1404 Posters & Publications. CLR1502 Posters & Publications. I-131-CLR1404 Posters & Publications. CLR1404 Posters & Publications. Posters & Publications. Events & Presentations. As seen in Science Translational Medicine. Alkylphosphocholine Analogs for Broad Spectrum Cancer Imaging and Therapy. Read our latest publication in Neurosurgery. Fluorescent Cancer-Selective Alkylphosphocholine Analogs for Intraoperative Glioma Detection. I-124-CLR1404 Phase 2 Trial. Jan 22, 2015.
cellect bio
Graft Versus Host Disease. Cellect Biotechnology was founded in 2011 with a mission to become a global leader in the next generation of cellular therapies by developing innovative solutions for immune system regeneration. Achieving higher selectivity, greater specificity and decreased toxicity, Cellect envisions its products becoming an integral and essential part of Bone Marrow Transplantation (BMT), as well as integrated into many aspects of regenerative medicine.
Cellect Biotech™ | Coming Soon...
T 44 (0)1565 650000. F 44 (0)1565 872734. Thank you for visiting Cellect Biotech. The main website is currently being developed and will launch soon. In the meantime, here is an introduction to who we are, and what we do. In order to bring this exciting innovation to market, the two companies have just signed a joint venture agreement and formed a new company called Cellect Biotech. Please download the recent press release in pdf format for more details.
cellectbudwig.com
Friday, 22.05.2015. Introduction to the Cellect-Budwig Protocol.
SOCIAL ENGAGEMENT